Methicillin-resistant Staphylococcus aureus and Vancomycin Prescribing in the Emergency Department: A Single-center Study Assessing Antibiotic Prescribing.

ABSTRACT:

Objectives

Given the support for methicillin-resistant Staphylococcus aureus (MRSA) antimicrobial stewardship in the 2021 Surviving Sepsis Campaign Guidelines, we sought to measure the use of vancomycin in the emergency department (ED) in the years preceding these recommendations.

Methods

A retrospective cohort study was conducted of all patients aged ≥ 18 years presenting to 5 emergency departments within a university-based health system who were given intravenous (IV) vancomycin during their ED index visit. The primary outcome assessed the proportion of patients with MRSA-positive blood cultures who received IV vancomycin in the ED. We also measured associations between clinical attributes associated with any MRSA infection.

Results

Of the 20,212 unique ED vi

SUBMITTER: Niforatos JD 

PROVIDER: S-EPMC11853012 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature